(Total Views: 325)
Posted On: 12/11/2019 4:23:44 PM
Post# of 148988
Thank you for sharing. On the one hand, it's great to see additional evidence that GvHD is another potential indication for leronlimab.
On the other hand, it's disappointing to see that leronlimab will probably be beaten to market by an inferior drug due to lack of funding at CYDY to pursue the indication aggressively.
Great science needs cash to fly!
On the other hand, it's disappointing to see that leronlimab will probably be beaten to market by an inferior drug due to lack of funding at CYDY to pursue the indication aggressively.
Great science needs cash to fly!
(1)
(0)Scroll down for more posts ▼
